Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11416376
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11416376 on ClinicalTrials.gov |
What this research studies
Researchers will set up systems to find people like me who have HIV and are newly diagnosed with Kaposi sarcoma by checking clinic records, lab and pathology reports, and doing community outreach. When someone is identified, the team will try to connect them quickly to HIV and cancer services and follow their health and treatment progress. The project partners with local clinics, hospitals, laboratories, and community health workers across East Africa to reach patients where they live. The information collected will be used to improve how quickly people get diagnosed and started on care in my community.
Who could benefit from this research
Good fit: People living with HIV in participating East African sites who are newly diagnosed with Kaposi sarcoma or have recent symptoms suggestive of KS are the ideal candidates.
Not a fit: Patients without Kaposi sarcoma, those outside the participating East African regions, or individuals already well connected to HIV and cancer care are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this could help people with HIV and Kaposi sarcoma start appropriate cancer and HIV treatment sooner, potentially improving health and survival.
How similar studies have performed: Similar rapid case-finding and linkage-to-care approaches have improved diagnosis and treatment uptake in other infectious disease and cancer programs, though applying this approach specifically to Kaposi sarcoma in East Africa is relatively novel.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BYAKWAGA, HELEN — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: BYAKWAGA, HELEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.